Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
There is a lot of competition, but still | Investor2014 | investorshub | 07/17/2024 4:23:36 PM |
True, but doesn't always hurt. | kevindenver | investorshub | 07/17/2024 4:20:39 PM |
I still believe in the CEO at $ANVS....seems | kevindenver | investorshub | 07/17/2024 4:17:06 PM |
Yea you are right my ignorant friend wonders | WolfofMia | investorshub | 07/17/2024 4:16:20 PM |
Landing closer to $4.6.. | KIPK | investorshub | 07/17/2024 4:13:23 PM |
SAVA has had a lot of shares traded | georgejjl | investorshub | 07/17/2024 4:11:27 PM |
What shares? I thought no one believes I | Investor2014 | investorshub | 07/17/2024 4:06:07 PM |
So did you sell your share yet? | WolfofMia | investorshub | 07/17/2024 3:51:08 PM |
You are absolutely correct about the following: | georgejjl | investorshub | 07/17/2024 3:43:05 PM |
An indictment-induced CEO resignation will do that to | boi568 | investorshub | 07/17/2024 3:42:49 PM |
were is the landing? | KIPK | investorshub | 07/17/2024 3:34:03 PM |
ouch! that hurts, but true | sab63090 | investorshub | 07/17/2024 3:09:31 PM |
My question: | sab63090 | investorshub | 07/17/2024 3:06:14 PM |
looks more like a drop from a 25 | sab63090 | investorshub | 07/17/2024 3:00:55 PM |
Early in the day observation: | sab63090 | investorshub | 07/17/2024 2:58:00 PM |
Seems to me that both the CEO and | sab63090 | investorshub | 07/17/2024 2:44:25 PM |
As it happens a lead plaintiff was appointed | Investor2014 | investorshub | 07/17/2024 2:11:10 PM |
Eggzactly. | ignatiusrielly35 | investorshub | 07/17/2024 1:49:41 PM |
No idea why you would invest in SAVA | Hosai | investorshub | 07/17/2024 1:36:20 PM |
FDA staff is probably reviewing any correspondence it's | boi568 | investorshub | 07/17/2024 1:35:02 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...